The clinical efficacy of breviscapine combined with beraprost on the treatment of diabetic peripheral neuropathy and its influence on serum high mobility group protein B1 and ischemia modified albumin levels

Bai Rujun; Zhang Hu; Chen Qi

doi:10.3760/j.issn.1673-4777.2022.01.015

Home>Articles>The clinical efficacy of breviscapine combined with beraprost on the treatment of diabetic peripheral neuropathy and its influence on serum high mobility group protein B1 and ischemia modified albumin levels

DOI: 10.3760/j.issn.1673-4777.2022.01.015

The clinical efficacy of breviscapine combined with beraprost on the treatment of diabetic peripheral neuropathy and its influence on serum high mobility group protein B1 and ischemia modified albumin levels

Bai Rujun

Zhang Hu

Chen Qi

Machine-generated Keywords：

Publication Date：2022-01-08

Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)

Pages：4( 64-67 )

China Medicine

ISTIC

ISSN：1673-4777

Year, Vol.(Issue)：2022,17(1)